tiprankstipranks
Advertisement
Advertisement
Immunic appoints Michael Bonney as chair
PremiumThe FlyImmunic appoints Michael Bonney as chair
21d ago
Immunic price target lowered to $19 from $26 at Roth Capital
Premium
The Fly
Immunic price target lowered to $19 from $26 at Roth Capital
25d ago
Immunic reports Q1 EPS ($1.08), consensus (96c)
Premium
The Fly
Immunic reports Q1 EPS ($1.08), consensus (96c)
27d ago
Why Is Vanguard Total Stock Market (VTI) ETF Down Today, 4/29/26?
PremiumMarket NewsWhy Is Vanguard Total Stock Market (VTI) ETF Down Today, 4/29/26?
1M ago
Why Is Vanguard Total Stock Market (VTI) ETF Down Today, 4/28/26?
Premium
Market News
Why Is Vanguard Total Stock Market (VTI) ETF Down Today, 4/28/26?
1M ago
Immunic Appoints Veteran Neurology Leader as Chief Medical Officer
Premium
Company Announcements
Immunic Appoints Veteran Neurology Leader as Chief Medical Officer
1M ago
Immunic Shareholders Approve Reverse Stock Split Initiative
PremiumCompany AnnouncementsImmunic Shareholders Approve Reverse Stock Split Initiative
2M ago
Immunic announces 1-for-10 reverse stock split
Premium
The Fly
Immunic announces 1-for-10 reverse stock split
2M ago
Immunic Buy Rating: Vidofludimus Calcium’s Differentiated Efficacy and Safety Profile vs. BTK Inhibitors in Relapsing MS
Premium
Ratings
Immunic Buy Rating: Vidofludimus Calcium’s Differentiated Efficacy and Safety Profile vs. BTK Inhibitors in Relapsing MS
2M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100